United States · 
What does NewSpring invest in?
NewSpring invests most often at Series A and Venture (60% of the rounds on record), in sectors such as Healthcare and Franchise.
NewSpring highlights
- 01
57 rounds on record
- 02
Mostly Series A and Venture: 60% of its rounds
- 03
Sole investor in 13 rounds, median $11M
- 04
10 exits from the portfolio
What they do
For more than 25 years, NewSpring has partnered with high-potential companies in the lower-middle market, delivering the guidance and capital they need at critical inflection points.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- HealthcareFranchise
- Based in
- Berwyn, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first57 appearances
- 2023
1 round
- Aug
- 2019
3 rounds
- Oct
- Oct
- Jun
- 2018
1 round
- Oct
- 2017
6 rounds
- Nov
- Oct
- Oct
- Oct
- Apr
- Mar
- 2016
4 rounds
- Dec
- Oct
- Aug
- Jun
- 2015
7 rounds
- Oct
- Oct
- Sept
- Jul
- Mar
- Feb
- Jan
- 2014
7 rounds
- Dec
- Oct
- Sept
- Sept
- Aug
- Aug
- Jun
- 2013
5 rounds
- Aug
- Jul
- Jul
- Jun
- Jun
- 2012
2 rounds
- Sept
- Apr
- 2011
4 rounds
- Sept
- Jul
- Apr
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration15 named
APAndrew P. PanzoMember of NSM SBIC II GP, LLC.iFiling they signed
BRBrian R. MurphyVice President and Member of NSM SBIC II GP, LLC.iFiling they signed
GTGlenn T. RiegerManaging MemberiForm ADV
GWGregory W. BargerVice PresidentiFiling they signed
JAJames AshtonMember of the Board of ManagersiFiling they signed
JSJonathan Spencer SchwartzChief Financial Officer, Treasurer and Secretary of issuer's Managing MemberiFiling they signed
LGLee GarberManager of the General PartneriFiling they signed
LRLeonard ReinhartDirectoriFiling they signed
MRMarc Richard LedermanChief Operating Officer, Secretary and Member of NSM SBIC II GP, LLC.iFiling they signed
MAMichael Anthony DipianoChief Executive Officer of the General PartneriFiling they signed
MAMichael AshkerDirectoriFiling they signed
PSPatrick SugrueManager of the General PartneriFiling they signed
SPSatya PonnuruManager of the General PartneriFiling they signed
SDSteven D. HobmanPresident and Member of NSM SBIC II GP, LLC.iFiling they signed
WMWalter ManerChief Executive Officer and Assistant Secretary of Issuer's Managing MemberiFiling they signed
We also hold 76 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$3.3Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Newspring Capital, LLC
- SEC number
- CRD 160608
Funds on its Form ADV
26 private funds, $3.2B in gross assets · filed Mar 2024
- NewSpring Mezzanine Capital IV, L.P.Private equity62 investors$419M
- NewSpring Growth Capital III, L.P.Private equity63 investors$369M
- NewSpring Growth Capital IV, L.P.Private equity51 investors$365M
- NewSpring Growth Capital V, L.P.Private equity146 investors$332M
- NewSpring Mezzanine Capital V, L.P.Private equity60 investors$321M
- NSH Verisma Holdco, L.P.Private equity31 investors$313M
- NewSpring Health Capital IV, L.P.Private equity150 investors$230M
- NewSpring Mezzanine Capital III, L.P.Private equity31 investors$175M
- NewSpring Holdings Parallel, LLCPrivate equity2 investors$124M
- NewSpring Holdings LLCPrivate equity10 investors$108M
And 16 more on the filing.
Exits from the portfolio
Companies it backed that were later bought or listed10 in all
iPipelineBought by Thoma BravoUndisclosedAug 2015
PrecyseBought by Pamplona Capital ManagementUndisclosedJun 2015
eXelateBought by Nielsen Holdings$200MMar 2015
RedPath Integrated PathologyBought by PDI,Inc.UndisclosedNov 2014
QuintiqBought by Dassault Systemes$337MJul 2014
EKR TherapeuticsBought by Cornerstone Therapeutics$150MMay 2012
CorrectNetBought by VistaOneUndisclosedMay 2011
Immune ControlBought by Corridor PharmaceuticalsUndisclosedJun 2010
RedPath Integrated PathologyBought by ExonHit Therapeutics$32MApr 2010
The FeedRoomBought by KIT digital$10MOct 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.
Companies it bought
Acquisitions by the firm itself
X5 SolutionsUndisclosedFeb 2015